Harry Janssen, MD, PhD

Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network
Toronto, ON, Canada

Disclosure information not submitted.

Presentation(s):

• D0519 - Safety and Efficacy of Oral TLR8 Agonist, Selgantolimod, in Viremic Adult Patients With Chronic Hepatitis B

  Tuesday, October 25, 2022
  10:00 AM – 12:00 PM ET